Pengana Capital Group Full Year 2025 Earnings: Misses Expectations

Pengana Capital Group (ASX:PCG) Full Year 2025 Results

Key Financial Results

• Revenue: AU$60.4m (up 49% from FY 2024).
• Net income: AU$2.61m (up from AU$4.35m loss in FY 2024).
• Profit margin: 4.3% (up from net loss in FY 2024). The move to profitability was driven by higher revenue.
• EPS: AU$0.029 (up from AU$0.052 loss in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Pengana Capital Group Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) also missed analyst estimates by 40%.

In the last 12 months, the only revenue segment was Development, Offering of and Management of Investment Funds contributing AU$60.4m. Notably, cost of sales worth AU$41.0m amounted to 68% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to AU$6.21m (37% of total expenses). Explore how PCG's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Capital Markets industry in Australia.

Performance of the Australian Capital Markets industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 2 warning signs for Pengana Capital Group that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.